Effect of docetaxel on metastatic tumor 18F-fluorocholine uptake in patients with hormone-refractory prostate cancer

被引：0
|
作者：
Kwee, Sandi [1 ]
Jiang, Caroline [2 ]
Lim, John [1 ]
Coel, Marc [1 ]
机构：
[1] Queens Med Ctr, Hamamatsu Queens PET Imaging Ctr, Honolulu, HI USA
[2] John A Burns Sch Med, Dept Med, Honolulu, HI USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2011年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1902
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Chemotherapy associated changes in metastatic tumor 18F-fluorocholine uptake and circulating DNA levels in hormone-refractory prostate cancer
    Kwee, Sandi
    Song, Min-Ae
    Loo, Lenora
    Cheng, Iona
    Tiirikainen, Maarit
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [2] Docetaxel in hormone-refractory metastatic prostate cancer
    Oh, WK
    DRUGS, 2005, 65 (16) : 2296 - 2297
  • [3] Biokinetic study of 18F-fluorocholine uptake to differentiate malignant and physiologic uptake of 18F-fluorocholine in prostate cancer metastases
    Wondergem, M.
    Knol, R. J. J.
    Van der Zant, F. M.
    Van der Ploeg, T.
    Pruim, J.
    De Jong, I. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S440 - S440
  • [4] Docetaxel and zoledronic acid in patients with metastatic hormone-refractory prostate cancer
    Vordos, D
    Paule, B
    Vacherot, F
    Allory, Y
    Salomon, L
    Hoznek, A
    Yiou, R
    Chopin, D
    Abbou, CC
    de la Taille, A
    BJU INTERNATIONAL, 2004, 94 (04) : 524 - 527
  • [5] 18F-fluorocholine uptake in Pagets disease in two patients with prostate cancer
    Abouzian, S.
    Fernandez, A.
    Lopez-Mora, D. A.
    Fuentes, F.
    Sizova, M.
    Carrio, I.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2020, 41 (02): : 108 - 109
  • [6] A weekly schedule of docetaxel for metastatic hormone-refractory prostate cancer
    Ferrero, JM
    Foa, C
    Thezenas, S
    Ronchin, P
    Peyrade, F
    Valenza, B
    Lesbats, G
    Garnier, G
    Boublil, JL
    Tchiknavorian, X
    Chevallier, D
    Amiel, J
    ONCOLOGY, 2004, 66 (04) : 281 - 287
  • [7] The influence of hormone therapy in 18F-fluorocholine PET in prostate cancer
    Lu, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S363 - S363
  • [8] Incidental uptake of 18F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer
    Hodolic, Marina
    Huchet, Virginie
    Balogova, Sona
    Michaud, Laure
    Kerrou, Khaldoun
    Nataf, Valerie
    Cimitan, Marino
    Fettich, Jure
    Talbot, Jean-Noel
    RADIOLOGY AND ONCOLOGY, 2014, 48 (03) : 228 - 234
  • [9] Quantification of 18F-Fluorocholine Kinetics in Patients with Prostate Cancer
    Verwer, Eline E.
    Oprea-Lager, Daniela E.
    van den Eertwegh, Alfons J. M.
    van Moorselaar, Reindert J. A.
    Windhorst, Albert D.
    Schwarte, Lothar A.
    Hendrikse, N. Harry
    Schuit, Robert C.
    Hoekstra, Otto S.
    Lammertsma, Adriaan A.
    Boellaard, Ronald
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03) : 365 - 371
  • [10] Effect of Erythropoietin on Bone Marrow Uptake of 18F-Fluorocholine in Prostate Cancer Comparison With 18F-Fluoride Uptake
    Balogova, Sona
    Huchet, Virginie
    Egrot, Christoph
    Michaud, Laure
    Paycha, F.
    Kerrou, Khaldoun
    Montravers, Francoise
    Cussenot, Olivier
    Talbot, Jean Noel
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (03) : 200 - 202
12345